Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Pediatric Protections Extended To Infant Formula, Dietary Ingredient Studies

This article was originally published in The Tan Sheet

Executive Summary

HHS protections covering children involved in clinical trials are extended to studies of new dietary supplement ingredients and infant formulas, as well as research supporting petitions for nutrient content or health claims, under an FDA interim rule published in the Federal Register April 24.

You may also be interested in...

Folic Acid, Birth Defects Research Addressed In Children's Health Bill

The "Children's Health Act of 2000" passed the House May 9 by a 419-2 vote under suspension of the rules. The bill (HR 4365) was introduced May 3 by Reps. Michael Bilirakis (R-Fla.) and Sherrod Brown (D-Ohio).

People In Brief

Perrigo promotes in pricing, planning

In Brief

Combe sells most of its OTC brands





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts